Monthly Meetings
Pharma Delegates conducts its meetings at noon on the third Wednesday of each month at the Tokyo American Club. Speakers have included Ministry officials, industry leaders in Japan and overseas, as well as science and technology experts, R&D executives, physicians, hospital pharmacists, HR specialists, CRO experts, academics, market researchers, industry analysts, economists, wholesalers and other entrepreneurs.
Next Meeting
Becoming AI-Native : How Leadership and Operating Models Must Change.’
Speaker: Yuto Ueda, Co-founder and Director / CAIO (Chief AI Officer) at GenerativeX, Inc
Date: 12-2PM, September 16th, 2026 @Tokyo American Club, 2 Chome-1-2 Azabudai, Minato City, Tokyo 106-8649
- What should leadership look like in the AI era?
- How do AI-native organizations and operating models evolve?
- What risks and opportunities do AI present for security?
Yuto graduated from the Faculty of Engineering at the University of Tokyo, and completed the university’s Graduate School of Engineering program in Technology Management Strategy (Matsuo Laboratory). Joined YCP Japan after graduation, where he worked on management consulting — including investment evaluation and strategic planning — as well as AI consulting and management of a portfolio company’s restaurant business. As a leader in corporate planning, he led internal business improvement initiatives and mid-term management plan development. He founded GenerativeX in June 2023 and has since driven numerous DX initiatives powered by generative AI. Specializing in the pharmaceutical industry, the company delivers generative AI implementation support across the entire value chain, from R&D through MR (medical representative) support. GenerativeX takes an implementation-first approach that goes beyond proof-of-concept — supporting clients from smallscale pilots through phased expansion to full operational adoption.
The schedule is as follows:
12:00 Cocktail
12:15〜13:00 Luncheon (seated)
13:00〜14:00 Lecture and Q&A
Lecture Structure:
30min : Presentation
15min : Interview
15min : Q&A
Past Meetings
| YEAR | DATE | Title and Speaker |
|---|---|---|
| 2024 | Sep. | Dr. Satoshi Ezoe, Deputy Assistant Minister for Global Health, MHLW. “Japan’s Global Health Diplomacy: A view from health diplomat ” |
| 2024 | Oct. | Dr. Masato Iwasaki, Senior Executive Fellow, Industrial Growth Platform, Inc. “Outlook of the future healthcare system in Japan and expectations to the pharmaceutical industry” |
| 2024 | Nov. | Dr. Yuanzhong Li, Senior Research Manager, Bioscience & Engineering laboratories, FUJIFILM Corporation “AI advances and FUJIFILM’s initiatives in healthcare” |
| 2024 | Dec. | Dr. Kenichi Oi ,Program Director, CANCER SUPPORT COMMUNITY JAPAN “Advancing Health Equity in Cancer Care and Work to Reduce Cancer Disparities: Multi-Partnership-led Grassroots Advocacy” |
| 2025 | Jan. | Mr. Rodrigo González, Ph.D., North Asia Director, Economist Intelligence Corporate Network(EICN)E “EICN Executive Briefing” |
| 2025 | Feb. | Mr. James Feliciano, Senior Advisor, AbbVie Japan Mr. Glen Argyle, President and Representative Director, Baxter Japan K.K. Mr. Jeremy Grossas, President and Representative Director, Merck Biopharma Japan Panel discussion : “Digital Engagement with HCPs: Strategic Imperatives for Pharma Leadership” |
| 2025 | Mar. | Mr. Hiroaki Ueno, Ph.D.,President of Japan Pharmaceutical Manufacturers Association（JPMA）. Representative Director, Mitsubishi Tanabe Pharma Corporation “Strengthening Drug Discovery Capabilities in Japan” |
| 2025 | Apr. | Prof. Toshio Miyata, Center for Translational and Advanced Research, Tohoku University Graduate School of Medicine “A drug from academia helps fight cancer and aging” |
| 2025 | May. | Mr. Alan Thomas, Senior Director, IQVIA Solutions Japan K.K. “Japan Pharma Market Dynamics – Update on 2024 and Outlook to 2029” |
| 2025 | June. | Year-end Special Seminar Mr. Osamu Kunii, MD, MPH, PhD Chief Executive Officer (CEO), Global Health Innovative Technology Fund (GHIT Fund) “The Past and Future of Global Health Issues, Architecture, and Solutions” |